{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-016496","form_type":"8-K","ticker":"PFSA","cik":"0001859807","company_name":"Profusa, Inc.","filed_at":"2026-02-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.585084+00:00","generated_at":"2026-05-16T02:49:51.790404+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"confidence":"high","headline":"Profusa signs exclusive worldwide license with Mayo Clinic for oxygen monitoring and CLTI","bullets":["Profusa granted exclusive worldwide license from Mayo for patent rights in continuous oxygen measurement and Critical Limb-Threatening Ischemia (CLTI).","Collaboration to support U.S. commercialization of Lumee wearable continuous tissue oxygen monitoring for critical limb ischemia.","Potential new indications include cardiovascular, renal, multi-organ, and orthopedic postoperative perfusion monitoring.","Profusa CEO notes over $100M invested in Lumee; Mayo retains financial interest for not-for-profit mission.","Financial terms include royalties on net sales, milestone payments, and share of sublicense income."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-016496","json":"https://secwatch.observer/filing/0001213900-26-016496.json","markdown":"https://secwatch.observer/filing/0001213900-26-016496.md","text":"https://secwatch.observer/filing/0001213900-26-016496.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1859807/000121390026016496/0001213900-26-016496-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1859807/000121390026016496/ea0277026-8k_profusa.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T02:49:51.790404+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}